Skip to main content

Table 3 Multivariate analysis of the CBCS clinicopathological variables in relation to overall survival in patients undergoing potentially curative resection for gastric cancer

From: Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection

Clinicopathological features

Multivariate analysis*

Internal validation*

HR (95% CI)

P

HR (95% CI)

P

Age

1.02 (1.02–1.03)

< 0.001

1.02 (1.02–1.03)

< 0.001

Tumor Location

 

< 0.001

 

< 0.001

 Upper

Reference

 

Reference

 

 Middle

0.92 (0.72–1.17)

 

0.91 (0.72–1.15)

 

 Lower

0.79 (0.64–0.97)

 

0.78 (0.64–0.96)

 

 Mixed

1.32 (1.03–1.70)

 

1.30 (1.02–1.66)

 

Tumor size (cm)

1.01 (1.00–1.01)

0.003

1.01 (1.00–1.01)

< 0.001

pTNM stage

 

< 0.001

 

< 0.001

 I

Reference

 

Reference

 

 II

2.00 (1.38–2.91)

 

2.02 (1.42–2.88)

 

 III

6.81 (4.92–9.42)

 

6.82 (4.97–9.36)

 

CBCS

 

< 0.001

 

< 0.001

 0

Reference

 

Reference

 

 1

1.29 (1.06–1.57)

 

1.27 (1.03–1.54)

 

 2

1.68 (1.35–2.09)

 

1.60 (1.22–1.94)

 
  1. *Adjusted for the following variables: age, BMI, ASA score, tumor location, vascular invasion, perineural invasion, pTNM stage, CBCS, and PLR